Copyright
©2013 Baishideng Publishing Group Co.
World J Diabetes. Oct 15, 2013; 4(5): 210-218
Published online Oct 15, 2013. doi: 10.4239/wjd.v4.i5.210
Published online Oct 15, 2013. doi: 10.4239/wjd.v4.i5.210
Table 2 Linear regression analysis for serum lipoprotein(a), by gender
Men (n = 165) | Women (n = 173) | |||||
β | SE | P value | β | SE | P value | |
Age (11 yr) | 1.05 | 1.11 | 0.59 | 0.78 | 1.01 | 0.007 |
Fasting glucose (24 mg/dL) | 0.82 | 1.12 | 0.14 | 0.66 | 1.18 | 0.018 |
Fasting insulin (mIU/L) | 0.82 | 1.28 | 0.43 | 0.75 | 1.32 | 0.31 |
Apo A-I/HDL-chol ratio (1 U) | 1.06 | 1.09 | 0.48 | 1.08 | 1.09 | 0.40 |
R2 = 0.01; P = 0.45 | R2 = 0.06; P = 0.014 |
- Citation: Onat A, Aydın M, Can G, Çakmak HA, Köroğlu B, Kaya A, Ademoğlu E. Impaired fasting glucose: Pro-diabetic, “atheroprotective” and modified by metabolic syndrome. World J Diabetes 2013; 4(5): 210-218
- URL: https://www.wjgnet.com/1948-9358/full/v4/i5/210.htm
- DOI: https://dx.doi.org/10.4239/wjd.v4.i5.210